Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 5/2023

22.12.2022 | Head and Neck

Relationships of orexigenic and anorexigenic hormones with body fat distribution in patients with obstructive sleep apnea syndrome

verfasst von: Arzu Or Koca, Ayşe İriz, Burak Hazır, Rabia Şemsi, Nirgül Bilger, Asiye Uğraş Dikmen, Aylin Sepici Dinçel, İlhan Yetkin

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to examine the relationships of disease activity and risk factors with serum levels of orexigenic and anorexigenic hormones in patients with obstructive sleep apnea syndrome (OSAS).

Methods

Fasting blood samples were taken for hormonal analysis of all participants, abdominal/neck bioimpedance measurements were recorded, and polysomnography (PSG) analyses were performed. According to the apnea–hypopnea index (AHI), 34 patients with newly diagnosed OSAS and 34 participants without OSAS were compared.

Results

The median body mass index (BMI) measured in the OSAS group was 30.39 kg/m2 and AHI was 18.95 and these values were 25.40 kg/m2 and 1.55 in the control group. There was a higher level of visceral adiposity and neuropeptide Y (NPY) in the moderate-to-severe OSAS group compared to the mild OSAS and control groups, and in the mild OSAS group compared to the control group (p = 0.001, p < 0.001). A positive correlation between the level of NPY and AHI and BMI (p < 0.001, p = 0.011), and a negative correlation between NPY levels and oxygen saturation (p = 0.001) was found. Oxygen saturation and desaturation rates were correlated with body fat percentage, body fat mass, abdominal adiposity, visceral adiposity, resting metabolic rate, and NPY levels.

Conclusions

The visceral adiposity ratio and increase in NPY levels are important parameters that increase the severity of OSAS. Considering the negative effects of NPY on vascular endothelium, measurement of basal NPY level before PSG in patients with OSAS is considered a parameter related to disease severity.
Literatur
1.
Zurück zum Zitat Li M, Li X, Lu Y (2018) Obstructive sleep apnea syndrome and metabolic diseases. Endocrinology 159:2670–2675CrossRefPubMed Li M, Li X, Lu Y (2018) Obstructive sleep apnea syndrome and metabolic diseases. Endocrinology 159:2670–2675CrossRefPubMed
2.
Zurück zum Zitat İriz A, Şemsi R, Eser B, Arslan B, Dinçel AS (2021) The evaluation of serum tryptophan and kynurenine levels in patients with obstructive sleep apnea syndrome. Sleep Breath 25:1389–1398CrossRefPubMed İriz A, Şemsi R, Eser B, Arslan B, Dinçel AS (2021) The evaluation of serum tryptophan and kynurenine levels in patients with obstructive sleep apnea syndrome. Sleep Breath 25:1389–1398CrossRefPubMed
3.
Zurück zum Zitat Mashaqi S, Badr MS (2019) The impact of obstructive sleep apnea and positive airway pressure therapy on metabolic peptides regulating appetite, food intake, energy homeostasis, and systemic inflammation: a literature review. J Clin Sleep Med 15:1037–1050CrossRefPubMedPubMedCentral Mashaqi S, Badr MS (2019) The impact of obstructive sleep apnea and positive airway pressure therapy on metabolic peptides regulating appetite, food intake, energy homeostasis, and systemic inflammation: a literature review. J Clin Sleep Med 15:1037–1050CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Valassi E, Scacchi M, Cavagnini F (2008) Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18:158–168CrossRefPubMed Valassi E, Scacchi M, Cavagnini F (2008) Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18:158–168CrossRefPubMed
5.
Zurück zum Zitat Barceló A, Barbé F, Llompart E, de la Peña M, Durán-Cantolla J, Ladaria A, Bosch M, Guerra L, Agustí AG (2005) Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171:183–187CrossRefPubMed Barceló A, Barbé F, Llompart E, de la Peña M, Durán-Cantolla J, Ladaria A, Bosch M, Guerra L, Agustí AG (2005) Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171:183–187CrossRefPubMed
6.
Zurück zum Zitat Yao XG, Yan ZT, Li NF, Wang YC, Li T, Zhu J, Zhou L, Shao L (2010) Serum neuropeptide Y level in hypertensive patients with obstructive sleep apnea syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 38:510–513PubMed Yao XG, Yan ZT, Li NF, Wang YC, Li T, Zhu J, Zhou L, Shao L (2010) Serum neuropeptide Y level in hypertensive patients with obstructive sleep apnea syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 38:510–513PubMed
7.
Zurück zum Zitat Sánchez-de-la-Torre M, Barceló A, Piérola J, Esquinas C, de la Peña M, Durán- Cantolla J, Capote F, Masa JF, Marin JM, Vilá M, Cao G, Martinez M, de Lecea L, Gozal D, Montserrat JM, Barbé F (2011) Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea. Respir Med 105:1954–1960CrossRefPubMed Sánchez-de-la-Torre M, Barceló A, Piérola J, Esquinas C, de la Peña M, Durán- Cantolla J, Capote F, Masa JF, Marin JM, Vilá M, Cao G, Martinez M, de Lecea L, Gozal D, Montserrat JM, Barbé F (2011) Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea. Respir Med 105:1954–1960CrossRefPubMed
8.
Zurück zum Zitat Assadi MH, Segev Y, Tarasiuk A (2019) Irreversible metabolic abnormalities following chronic upper airway loading. Sleep 42:zsz176CrossRefPubMed Assadi MH, Segev Y, Tarasiuk A (2019) Irreversible metabolic abnormalities following chronic upper airway loading. Sleep 42:zsz176CrossRefPubMed
9.
Zurück zum Zitat Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224CrossRefPubMed Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224CrossRefPubMed
10.
Zurück zum Zitat Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM, American Academy of Sleep Medicine (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 8:597–619CrossRefPubMedPubMedCentral Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM, American Academy of Sleep Medicine (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 8:597–619CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Yuan H, Schwab RJ, Kim C, He J, Shults J, Bradford R, Huang J, Marcus CL (2013) Relationship between body fat distribution and upper airway dynamic function during sleep in adolescents. Sleep 36:1199–1207CrossRefPubMedPubMedCentral Yuan H, Schwab RJ, Kim C, He J, Shults J, Bradford R, Huang J, Marcus CL (2013) Relationship between body fat distribution and upper airway dynamic function during sleep in adolescents. Sleep 36:1199–1207CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ahbab S, Ataoğlu HE, Tuna M, Karasulu L, Cetin F, Temiz LU, Yenigün M (2013) Neck circumference, metabolic syndrome and obstructive sleep apnea syndrome; evaluation of possible linkage. Med Sci Monit 19:111–117CrossRefPubMedPubMedCentral Ahbab S, Ataoğlu HE, Tuna M, Karasulu L, Cetin F, Temiz LU, Yenigün M (2013) Neck circumference, metabolic syndrome and obstructive sleep apnea syndrome; evaluation of possible linkage. Med Sci Monit 19:111–117CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yu X, Fujimoto K, Urushibata K, Matsuzawa Y, Kubo K (2003) Cephalometric analysis in obese and nonobese patients with obstructive sleep apnea syndrome. Chest 124:212–218CrossRefPubMed Yu X, Fujimoto K, Urushibata K, Matsuzawa Y, Kubo K (2003) Cephalometric analysis in obese and nonobese patients with obstructive sleep apnea syndrome. Chest 124:212–218CrossRefPubMed
14.
Zurück zum Zitat Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131:1387–1392CrossRefPubMed Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131:1387–1392CrossRefPubMed
15.
Zurück zum Zitat Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A (2011) Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 12:80CrossRefPubMedPubMedCentral Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A (2011) Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 12:80CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Yosunkaya Ş, Okur HK, Can Ü, Zamani A, Kutlu R (2015) Impact of continuous positive airway pressure treatment on leptin levels in patients with obstructive sleep apnea syndrome. Metab Syndr Relat Disord 13:272–277CrossRefPubMed Yosunkaya Ş, Okur HK, Can Ü, Zamani A, Kutlu R (2015) Impact of continuous positive airway pressure treatment on leptin levels in patients with obstructive sleep apnea syndrome. Metab Syndr Relat Disord 13:272–277CrossRefPubMed
17.
Zurück zum Zitat Li NF, Yao XG, Zhu J, Yang J, Liu KJ, Wang YC, Wang XL, Zu FY (2010) Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens 32:54–60CrossRefPubMed Li NF, Yao XG, Zhu J, Yang J, Liu KJ, Wang YC, Wang XL, Zu FY (2010) Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens 32:54–60CrossRefPubMed
18.
Zurück zum Zitat Tang X, Yang LX, Zhang M, Zhao WX, Lu JC, Duan ZJ, Zhou N, Yan J (2018) Cognitive status and its relationship with serum neuropeptide Y in patients with obstructive sleep apnea hypopnea syndrome. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 32:1414–1417PubMed Tang X, Yang LX, Zhang M, Zhao WX, Lu JC, Duan ZJ, Zhou N, Yan J (2018) Cognitive status and its relationship with serum neuropeptide Y in patients with obstructive sleep apnea hypopnea syndrome. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 32:1414–1417PubMed
19.
Zurück zum Zitat Papaioannou I, Patterson M, Twigg GL, Vazir A, Ghatei M, Morrell MJ, Polkey MI (2011) Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. J Clin Sleep Med 7:486–492CrossRefPubMedPubMedCentral Papaioannou I, Patterson M, Twigg GL, Vazir A, Ghatei M, Morrell MJ, Polkey MI (2011) Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. J Clin Sleep Med 7:486–492CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Wang W, Li Q, Pan Y, Zhu D, Wang L (2013) Influence of hypercapnia on the synthesis of neuropeptides and their receptors in murine brain. Respirology 18:102–107CrossRefPubMed Wang W, Li Q, Pan Y, Zhu D, Wang L (2013) Influence of hypercapnia on the synthesis of neuropeptides and their receptors in murine brain. Respirology 18:102–107CrossRefPubMed
21.
Zurück zum Zitat Bhushan B, Guleria R, Misra A, Luthra K, Kumar G (2011) Association of PPARγ2 (Pro12Ala) and neuropeptide Y (Leu7Pro) gene polymorphisms with obstructive sleep apnea in obese Asian Indians. Dis Mark 30:31–38CrossRef Bhushan B, Guleria R, Misra A, Luthra K, Kumar G (2011) Association of PPARγ2 (Pro12Ala) and neuropeptide Y (Leu7Pro) gene polymorphisms with obstructive sleep apnea in obese Asian Indians. Dis Mark 30:31–38CrossRef
22.
Zurück zum Zitat Antonijevic IA, Murck H, Bohlhalter S, Frieboes RM, Holsboer F, Steiger A (2000) Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 39:1474–1481CrossRefPubMed Antonijevic IA, Murck H, Bohlhalter S, Frieboes RM, Holsboer F, Steiger A (2000) Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 39:1474–1481CrossRefPubMed
23.
Zurück zum Zitat Li MM, Zheng YL, Wang WD, Lin S, Lin HL (2021) Neuropeptide Y: an update on the mechanism underlying chronic intermittent hypoxia-induced endothelial dysfunction. Front Physiol 12:712281CrossRefPubMedPubMedCentral Li MM, Zheng YL, Wang WD, Lin S, Lin HL (2021) Neuropeptide Y: an update on the mechanism underlying chronic intermittent hypoxia-induced endothelial dysfunction. Front Physiol 12:712281CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Harańczyk M, Konieczyńska M, Płazak W (2022) Endothelial dysfunction in obstructive sleep apnea patients. Sleep Breath 26:231–242CrossRefPubMed Harańczyk M, Konieczyńska M, Płazak W (2022) Endothelial dysfunction in obstructive sleep apnea patients. Sleep Breath 26:231–242CrossRefPubMed
25.
Zurück zum Zitat Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM (2009) Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ 108:246–249PubMedPubMedCentral Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM (2009) Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ 108:246–249PubMedPubMedCentral
26.
Zurück zum Zitat Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J, TURDEP-II Study Group (2013) Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28:169–180CrossRefPubMedPubMedCentral Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, Karsidag K, Genc S, Telci A, Canbaz B, Turker F, Yilmaz T, Cakir B, Tuomilehto J, TURDEP-II Study Group (2013) Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28:169–180CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Tachikawa R, Ikeda K, Minami T, Matsumoto T, Hamada S, Murase K, Tanizawa K, Inouchi M, Oga T, Akamizu T, Mishima M, Chin K (2016) Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 194:729–738CrossRefPubMed Tachikawa R, Ikeda K, Minami T, Matsumoto T, Hamada S, Murase K, Tanizawa K, Inouchi M, Oga T, Akamizu T, Mishima M, Chin K (2016) Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 194:729–738CrossRefPubMed
Metadaten
Titel
Relationships of orexigenic and anorexigenic hormones with body fat distribution in patients with obstructive sleep apnea syndrome
verfasst von
Arzu Or Koca
Ayşe İriz
Burak Hazır
Rabia Şemsi
Nirgül Bilger
Asiye Uğraş Dikmen
Aylin Sepici Dinçel
İlhan Yetkin
Publikationsdatum
22.12.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 5/2023
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-022-07799-5

Weitere Artikel der Ausgabe 5/2023

European Archives of Oto-Rhino-Laryngology 5/2023 Zur Ausgabe

ACKNOWLEDGEMENT TO REFEREES

Acknowledgement to referees 2022

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.